Long-term outcome of intravitreal ranibizumab treatment, compared with photodynamic therapy, in patients with polypoidal choroidal vasculopathy.
about
Polypoidal Choroidal Vasculopathy in AsiansCombined intravitreal anti-VEGF and photodynamic therapy versus photodynamic monotherapy for polypoidal choroidal vasculopathy: a systematic review and meta-analysis of comparative studiesComparison between 1-year outcomes of aflibercept with and without photodynamic therapy for polypoidal choroidal vasculopathy: Retrospective observation study.Ranibizumab for the treatment of degenerative ocular conditions.Individualized ranibizumab therapy strategies in year 3 after as-needed treatment for polypoidal choroidal vasculopathy.Photodynamic therapy versus anti-vascular endothelial growth factor agents for polypoidal choroidal vasculopathy: a meta-analysisRanibizumab alone or in combination with photodynamic therapy vs photodynamic therapy for polypoidal choroidal vasculopathy: a systematic review and Meta-analysisPracticability confirmation by meta-analysis of intravitreal ranibizumab compared to photodynamic therapy to treat polypoidal choroidal vasculopathy.Intravitreal Anti-vascular Endothelial Growth Factor for Treating Polypoidal Choroidal Vasculopathy with Grape-like Polyp Clusters.Comparison of the 1-year Outcomes of Conbercept Therapy between Two Different Angiographic Subtypes of Polypoidal Choroidal Vasculopathy.Efficacy of fixed-dosing aflibercept for treating polypoidal choroidal vasculopathy: 1-year results of the VAULT study.Combined therapy versus anti-vascular endothelial growth factor monotherapy for polypoidal choroidal vasculopathy: a Meta-analysis.Macular hemorrhage as a cause of acute angle closure - Photodynamic therapy and polypoidal choroidal vasculopathy.Baseline polyp size as a potential predictive factor for recurrence of polypoidal choroidal vasculopathy.Polypoidal choroidal vasculopathy treatment options: A meta-analysis.Three-year visual outcomes of intravitreal ranibizumab with or without photodynamic therapy for polypoidal choroidal vasculopathy.Comparison of the effects of photodynamic therapy, intravitreal ranibizumab and combination for polypoidal choroidal vasculopathy under 1 + PRN regimen.Complete regression of branching vascular network in polypoidal choroidal vasculopathy by ranibizumab and photodynamic therapy, two case reports
P2860
Q26799548-7BA1CF24-E4BF-467C-8477-0F5E626BB82CQ26995216-3690BBD2-A51F-4E23-8F6C-5723A93DCB12Q33632486-634FDBD5-8413-4AB3-86FF-28CB0F872CC9Q33831237-AE529609-2134-4377-8F83-E6BE4729D757Q35368673-39BECF92-EE9B-4B0C-B0BF-4FCE4267AB9FQ35713167-BAF46EED-4487-4218-9D09-7676B974DF9CQ35838315-C0AEFB35-5AD8-47E3-993F-CA005C953DD8Q36136227-8254FB6F-1B1E-48BE-B3C6-C1C5D3C00BA9Q37136866-F0895595-89F1-422F-A40C-043C76B30CB0Q37445392-1803B6FE-1AE0-4A19-8D1B-F6F2F2E3D0B2Q37662693-D2E8CEB5-E218-4F72-985C-BACA72E3B114Q38598693-67CC95BA-1979-441C-AB18-11662428D95EQ43057281-33240102-F3DA-433C-ACC9-CAC3340F33BDQ47338796-0F5BA429-202F-405B-B0D7-F72EA97F6EFFQ48239027-3CE0CD97-7885-4E3A-8581-A2F3D5304283Q50227158-12E4587A-7E9B-4938-A442-0D568533DE53Q55431176-A885E9B9-AA51-4AF1-840D-9C3D3857C8AFQ58613700-A15F6386-C1CF-44F3-B2F2-6B647576976D
P2860
Long-term outcome of intravitreal ranibizumab treatment, compared with photodynamic therapy, in patients with polypoidal choroidal vasculopathy.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 23 August 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Long-term outcome of intravitr ...... poidal choroidal vasculopathy.
@en
Long-term outcome of intravitr ...... poidal choroidal vasculopathy.
@nl
type
label
Long-term outcome of intravitr ...... poidal choroidal vasculopathy.
@en
Long-term outcome of intravitr ...... poidal choroidal vasculopathy.
@nl
prefLabel
Long-term outcome of intravitr ...... poidal choroidal vasculopathy.
@en
Long-term outcome of intravitr ...... poidal choroidal vasculopathy.
@nl
P2093
P2860
P356
P1433
P1476
Long-term outcome of intravitr ...... poidal choroidal vasculopathy.
@en
P2093
P2860
P2888
P304
1013-20; quiz 1021
P356
10.1038/EYE.2013.179
P577
2013-08-23T00:00:00Z